90 filings
Page 2 of 5
8-K
6360xpvo
17 Oct 23
Nuvalent Announces Pricing of Public Offering of Common Stock
4:07pm
424B5
vzyp73 8khmxit21fwi
17 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
c5dc27zswqn fooo
16 Oct 23
Prospectus supplement for primary offering
7:39am
8-K
pz23d6sdm1ad sy
13 Oct 23
Nuvalent Reports Preliminary Phase 1 Clinical Data from ALKOVE-1 Trial
6:40am
8-K
1yytfjldnt7mw0nn14ii
4 Oct 23
Other Events
4:05pm
8-K
b39x23ngaqwi9m22q7yr
10 Aug 23
Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results
6:45am
8-K
ibjd3 ydp1i
16 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:08pm
8-K
vkuyr
11 May 23
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
6:39am
ARS
nz8oj
28 Apr 23
Annual report to shareholders
4:17pm
DEFA14A
to3v2ol1p2k
28 Apr 23
Additional proxy soliciting materials
12:00am
PRE 14A
bdc08eb u9rch
13 Apr 23
Preliminary proxy
4:30pm
S-8
j4c2sgixh
16 Mar 23
Registration of securities for employees
7:36am
S-3ASR
p01xd6o xv7xsbow6xms
16 Mar 23
Automatic shelf registration
7:29am
8-K
a0x c6jjxdla
16 Mar 23
Nuvalent Highlights Pipeline and Business Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
6:36am
8-K
0eixi3u17wo
10 Mar 23
Regulation FD Disclosure
8:38pm